Free Trial

Indaptus Therapeutics (INDP) Short Interest Ratio & Short Volume

Indaptus Therapeutics logo
$9.89 -0.57 (-5.45%)
Closing price 07/24/2025 03:59 PM Eastern
Extended Trading
$10.12 +0.23 (+2.33%)
As of 07/24/2025 07:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Indaptus Therapeutics Short Interest Data

Indaptus Therapeutics (INDP) has a short interest of 29,900 shares, representing 5.22% of the float (the number of shares available for trading by the public). This marks a -96.00% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 31,914 shares to cover all short positions.

Current Short Interest
29,900 shares
Previous Short Interest
748,000 shares
Change Vs. Previous Month
-96.00%
Dollar Volume Sold Short
$314.85 thousand
Short Interest Ratio
0.1 Days to Cover
Last Record Date
June 30, 2025
Outstanding Shares
570,000 shares
Float Size
572,700 shares
Short Percent of Float
5.22%
Today's Trading Volume
5,228 shares
Average Trading Volume
31,914 shares
Today's Volume Vs. Average
16%
Short Selling Indaptus Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Indaptus Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

INDP Short Interest Over Time

INDP Days to Cover Over Time

INDP Percentage of Float Shorted Over Time

Indaptus Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/30/202529,900 shares $314.85 thousand -96.0%5.2%0.1 $10.53
6/15/2025748,000 shares $242.95 thousand -26.7%5.8%0.1 $0.32
5/31/20251,020,000 shares $343.33 thousand +1,157.7%7.9%1.5 $0.34
5/15/202581,100 shares $34.06 thousand -32.4%0.6%0.2 $0.42
4/30/2025119,900 shares $55.15 thousand -8.5%0.9%0.3 $0.46
4/15/2025131,100 shares $66.11 thousand -40.7%1.0%0.3 $0.50
3/31/2025221,200 shares $121.64 thousand +322.1%1.9%0.6 $0.55
3/15/202552,400 shares $42.19 thousand -10.0%0.5%0.1 $0.81
2/28/202558,200 shares $48.83 thousand -25.9%0.5%2.5 $0.84
2/15/202578,500 shares $62.72 thousand +102.8%0.7%3.1 $0.80
1/31/202538,700 shares $35.22 thousand -41.7%0.4%1.6 $0.91
1/15/202566,400 shares $57.77 thousand -11.2%0.7%0.6 $0.87
12/31/202474,800 shares $62.99 thousand -19.1%0.8%0.7 $0.84
12/15/202492,500 shares $92.50 thousand +0.5%1.0%0.8 $1.00
11/30/202492,000 shares $93.84 thousand +8.2%1.1%0.8 $1.02
11/15/202485,000 shares $94.35 thousand -38.7%1.1%0.8 $1.11
10/31/2024138,700 shares $162.28 thousand +348.9%1.9%1.3 $1.17
10/15/202430,900 shares $39.24 thousand -9.7%0.4%0.3 $1.27
9/30/202434,200 shares $42.41 thousand +284.3%0.5%2.5 $1.24
9/15/20248,900 shares $13.44 thousand +140.5%0.1%0.7 $1.51
8/31/20243,700 shares $6.10 thousand -47.9%0.1%0.3 $1.65
8/15/20247,100 shares $11.86 thousand -12.4%0.1%0.4 $1.67
7/31/20248,100 shares $16.52 thousand -42.6%0.1%0.4 $2.04
7/15/202414,100 shares $31.02 thousand +147.4%0.2%0.7 $2.20
6/30/20245,700 shares $12.08 thousand +9.6%0.1%0.2 $2.12
6/15/20245,200 shares $12.84 thousand -66.7%0.1%0.2 $2.47
5/31/202415,600 shares $36.97 thousand -6.0%0.3%0.5 $2.37
5/15/202416,600 shares $36.69 thousand -35.7%0.3%0.2 $2.21
4/30/202425,800 shares $55.99 thousand -70.1%0.4%0.3 $2.17
4/15/202486,200 shares $228.43 thousand -13.9%1.5%1 $2.65
3/31/2024100,100 shares $224.22 thousand +0.7%1.7%1.3 $2.24
3/15/202499,400 shares $185.88 thousand +196.7%1.7%1.3 $1.87
2/29/202433,500 shares $73.70 thousand +94.8%0.6%0.5 $2.20
2/15/202417,200 shares $29.93 thousand +18.6%0.3%1.8 $1.74
1/31/202414,500 shares $23.93 thousand -20.8%0.3%1.5 $1.65
1/15/202418,300 shares $33.86 thousand -10.7%0.3%1.3 $1.85
12/31/202320,500 shares $36.08 thousand -9.3%0.4%1.5 $1.76
12/15/202322,600 shares $44.75 thousand -2.6%0.4%1.7 $1.98
11/30/202323,200 shares $52.43 thousand +21.5%0.4%1.4 $2.26
11/15/202319,100 shares $42.02 thousand +64.7%0.3%1 $2.20
Is Elon's empire crumbling? (Ad)

The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

Click here to see the Tesla shock that could blindside everyone.
10/31/202311,600 shares $26.45 thousand -3.3%0.2%0.5 $2.28
10/15/202312,000 shares $30.72 thousand -14.3%0.2%0.6 $2.56
9/30/202314,000 shares $38.57 thousand -31.7%0.2%0.7 $2.76
9/15/202320,500 shares $69.29 thousand -9.3%0.4%1 $3.38
8/31/202322,600 shares $64.86 thousand -51.6%0.4%1.3 $2.87
8/15/202346,700 shares $104.61 thousand +115.2%0.8%2.8 $2.24
7/31/202321,700 shares $44.92 thousand +29.9%0.4%1.6 $2.07
7/15/202316,700 shares $31.73 thousand -1.8%0.3%1.3 $1.90
6/30/202317,000 shares $32.47 thousand -28.3%0.3%0.6 $1.91
6/15/202323,700 shares $46.45 thousand -11.9%0.4%0.8 $1.96
5/31/202326,900 shares $43.85 thousand -0.4%0.5%0.9 $1.63
5/15/202327,000 shares $56.16 thousand -51.4%0.5%1 $2.08
4/30/202355,600 shares $145.06 thousand +159.8%1.0%2 $2.61
4/15/202321,400 shares $41.73 thousand -9.3%0.4%0.8 $1.95
3/31/202323,600 shares $43.66 thousand -12.6%0.4%3.1 $1.85
3/15/202327,000 shares $41.04 thousand +4.7%0.5%2.9 $1.52
2/28/202325,800 shares $45.15 thousand -21.3%0.5%1 $1.75
2/15/202332,800 shares $58.71 thousand -16.1%0.6%1.3 $1.79
1/31/202339,100 shares $69.21 thousand +3.7%0.7%1.5 $1.77
1/15/202337,700 shares $61.45 thousand -29.8%0.7%1.5 $1.63
12/30/202253,700 shares $77.87 thousand -46.3%1.1%2.2 $1.45
12/15/2022100,000 shares $195 thousand +498.8%2.0%4.2 $1.95
11/30/202216,700 shares $30.42 thousand -4.6%0.3%1.6 $1.82
11/15/202217,500 shares $30.28 thousand +5.4%0.4%1.6 $1.73
10/31/202216,600 shares $30.38 thousand +9.2%0.3%1.4 $1.83
10/15/202215,200 shares $27.36 thousand -14.6%0.3%1.1 $1.80
9/30/202217,800 shares $38.45 thousand -21.9%0.4%1.1 $2.16
9/15/202222,800 shares $61.10 thousand -8.1%0.5%0.9 $2.68
8/31/202224,800 shares $62.50 thousand -31.7%0.5%0.7 $2.52
8/15/202236,300 shares $105.27 thousand -36.9%0.7%0.6 $2.90
7/31/202257,500 shares $163.30 thousand -25.3%1.1%0.1 $2.84
7/15/202277,000 shares $256.41 thousand +49.8%1.5%0.2 $3.33
6/30/202251,400 shares $134.15 thousand -42.6%1.0%0.1 $2.61
6/15/202289,500 shares $200.48 thousand -50.9%1.6%0.2 $2.24
5/31/2022182,100 shares $460.71 thousand +569.5%3.2%0.4 $2.53
5/15/202227,200 shares $67.46 thousand -38.3%0.5%0.1 $2.48
4/30/202244,100 shares $129.21 thousand -14.7%0.8%1 $2.93
4/15/202251,700 shares $177.33 thousand -18.1%0.9%0.9 $3.43
3/31/202263,100 shares $252.40 thousand -30.6%1.1%0.8 $4.00
3/15/202290,900 shares $289.97 thousand +21.2%1.6%0.6 $3.19
2/28/202275,000 shares $313.50 thousand +6.8%1.4%0.4 $4.18
2/15/202270,200 shares $351 thousand -34.2%1.3%0.3 $5.00
1/31/2022106,600 shares $531.93 thousand +2.8%1.9%0.4 $4.99
1/15/2022103,700 shares $547.54 thousand +157.3%1.9%0.4 $5.28
12/31/202140,300 shares $229.71 thousand No Change0.7%0.1 $5.70

INDP Short Interest - Frequently Asked Questions

What is Indaptus Therapeutics' current short interest?

Short interest is the volume of Indaptus Therapeutics shares that have been sold short but have not yet been closed out or covered. As of June 30th, traders have sold 29,900 shares of INDP short. 5.22% of Indaptus Therapeutics' shares are currently sold short. Learn More on Indaptus Therapeutics' current short interest.

What is a good short interest percentage for Indaptus Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.22% of Indaptus Therapeutics' floating shares are currently sold short.

Is Indaptus Therapeutics' short interest increasing or decreasing?

Indaptus Therapeutics saw a decline in short interest during the month of June. As of June 30th, there was short interest totaling 29,900 shares, a decline of 96.0% from the previous total of 748,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Indaptus Therapeutics' float size?

Indaptus Therapeutics currently has issued a total of 570,000 shares. Some of Indaptus Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Indaptus Therapeutics currently has a public float of 572,700 shares.

How does Indaptus Therapeutics' short interest compare to its competitors?

5.22% of Indaptus Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Indaptus Therapeutics: Moleculin Biotech, Inc. (15.64%), Tempest Therapeutics, Inc. (9.67%), Cingulate Inc. (4.75%), Dare Bioscience, Inc. (0.54%), Pulmatrix, Inc. (0.46%), CytoMed Therapeutics Limited (1.42%), Elevation Oncology, Inc. (3.92%), Aytu BioPharma Inc. (9.12%), Lisata Therapeutics, Inc. (0.46%), Natural Alternatives International, Inc. (0.45%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks.

What does it mean to sell short Indaptus Therapeutics stock?

Short selling INDP is an investing strategy that aims to generate trading profit from Indaptus Therapeutics as its price is falling. INDP shares are trading down $0.57 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Indaptus Therapeutics?

A short squeeze for Indaptus Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of INDP, which in turn drives the price of the stock up even further.

How often is Indaptus Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INDP, twice per month. The most recent reporting period available is June, 30 2025.




This page (NASDAQ:INDP) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners